Literature DB >> 16540960

Esophageal and transpulmonary pressures in acute respiratory failure.

Daniel Talmor1, Todd Sarge, Carl R O'Donnell, Ray Ritz, Atul Malhotra, Alan Lisbon, Stephen H Loring.   

Abstract

OBJECTIVE: Pressure inflating the lung during mechanical ventilation is the difference between pressure applied at the airway opening (Pao) and pleural pressure (Ppl). Depending on the chest wall's contribution to respiratory mechanics, a given positive end-expiratory and/or end-inspiratory plateau pressure may be appropriate for one patient but inadequate or potentially injurious for another. Thus, failure to account for chest wall mechanics may affect results in clinical trials of mechanical ventilation strategies in acute respiratory distress syndrome. By measuring esophageal pressure (Pes), we sought to characterize influence of the chest wall on Ppl and transpulmonary pressure (PL) in patients with acute respiratory failure.
DESIGN: Prospective observational study.
SETTING: Medical and surgical intensive care units at Beth Israel Deaconess Medical Center. PATIENTS: Seventy patients with acute respiratory failure.
INTERVENTIONS: Placement of esophageal balloon-catheters.
MEASUREMENTS AND MAIN RESULTS: Airway, esophageal, and gastric pressures recorded at end-exhalation and end-inflation Pes averaged 17.5 +/- 5.7 cm H2O at end-expiration and 21.2 +/- 7.7 cm H2O at end-inflation and were not significantly correlated with body mass index or chest wall elastance. Estimated PL was 1.5 +/- 6.3 cm H2O at end-expiration, 21.4 +/- 9.3 cm H2O at end-inflation, and 18.4 +/- 10.2 cm H2O (n = 40) during an end-inspiratory hold (plateau). Although PL at end-expiration was significantly correlated with positive end-expiratory pressure (p < .0001), only 24% of the variance in PL was explained by Pao (R = .243), and 52% was due to variation in Pes.
CONCLUSIONS: In patients in acute respiratory failure, elevated esophageal pressures suggest that chest wall mechanical properties often contribute substantially and unpredictably to total respiratory impedance, and therefore Pao may not adequately predict PL or lung distention. Systematic use of esophageal manometry has the potential to improve ventilator management in acute respiratory failure by providing more direct assessment of lung distending pressure.

Entities:  

Mesh:

Year:  2006        PMID: 16540960      PMCID: PMC2278169          DOI: 10.1097/01.CCM.0000215515.49001.A2

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

Review 1.  Lung injury caused by mechanical ventilation.

Authors:  A S Slutsky
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

2.  IMPROVED TECHNIQUE FOR ESTIMATING PLEURAL PRESSURE FROM ESOPHAGEAL BALLOONS.

Authors:  J MILIC-EMILI; J MEAD; J M TURNER; E M GLAUSER
Journal:  J Appl Physiol       Date:  1964-03       Impact factor: 3.531

3.  Volume-related and volume-independent effects of posture on esophageal and transpulmonary pressures in healthy subjects.

Authors:  George R Washko; Carl R O'Donnell; Stephen H Loring
Journal:  J Appl Physiol (1985)       Date:  2005-11-23

4.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.

Authors:  M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

5.  Validation of esophageal balloon technique at different lung volumes and postures.

Authors:  A Baydur; E J Cha; C S Sassoon
Journal:  J Appl Physiol (1985)       Date:  1987-01

6.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

7.  Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model.

Authors:  L Tremblay; F Valenza; S P Ribeiro; J Li; A S Slutsky
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Authors:  V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

9.  Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group.

Authors:  T E Stewart; M O Meade; D J Cook; J T Granton; R V Hodder; S E Lapinsky; C D Mazer; R F McLean; T S Rogovein; B D Schouten; T R Todd; A S Slutsky
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

10.  Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS.

Authors:  L Brochard; F Roudot-Thoraval; E Roupie; C Delclaux; J Chastre; E Fernandez-Mondéjar; E Clémenti; J Mancebo; P Factor; D Matamis; M Ranieri; L Blanch; G Rodi; H Mentec; D Dreyfuss; M Ferrer; C Brun-Buisson; M Tobin; F Lemaire
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

View more
  86 in total

1.  Maintaining end-expiratory transpulmonary pressure prevents worsening of ventilator-induced lung injury caused by chest wall constriction in surfactant-depleted rats.

Authors:  Stephen H Loring; Matteo Pecchiari; Patrizia Della Valle; Ario Monaco; Guendalina Gentile; Edgardo D'Angelo
Journal:  Crit Care Med       Date:  2010-12       Impact factor: 7.598

Review 2.  Fifty Years of Research in ARDS. Setting Positive End-Expiratory Pressure in Acute Respiratory Distress Syndrome.

Authors:  Sarina K Sahetya; Ewan C Goligher; Roy G Brower
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

3.  CrossTalk opposing view: there is not added benefit to providing permissive hypercapnia in the treatment of ARDS.

Authors:  Jeremy R Beitler; Rolf D Hubmayr; Atul Malhotra
Journal:  J Physiol       Date:  2013-06-01       Impact factor: 5.182

4.  Measurements Obtained From Esophageal Balloon Catheters Are Affected by the Esophageal Balloon Filling Volume in Children With ARDS.

Authors:  Justin C Hotz; Cary T Sodetani; Jeffrey Van Steenbergen; Robinder G Khemani; Timothy W Deakers; Christopher J Newth
Journal:  Respir Care       Date:  2017-10-31       Impact factor: 2.258

Review 5.  Obesity and the lung: 3. Obesity, respiration and intensive care.

Authors:  A Malhotra; D Hillman
Journal:  Thorax       Date:  2008-10       Impact factor: 9.139

6.  The polycompartment syndrome: towards an understanding of the interactions between different compartments!

Authors:  Manu L N G Malbrain; Alexander Wilmer
Journal:  Intensive Care Med       Date:  2007-09-01       Impact factor: 17.440

7.  Esophageal pressures in acute lung injury: do they represent artifact or useful information about transpulmonary pressure, chest wall mechanics, and lung stress?

Authors:  Stephen H Loring; Carl R O'Donnell; Negin Behazin; Atul Malhotra; Todd Sarge; Ray Ritz; Victor Novack; Daniel Talmor
Journal:  J Appl Physiol (1985)       Date:  2009-12-17

8.  Abdominal compartment syndrome.

Authors:  Manu Malbrain
Journal:  F1000 Med Rep       Date:  2009-11-16

9.  Effects of positive end-expiratory pressure on respiratory function and hemodynamics in patients with acute respiratory failure with and without intra-abdominal hypertension: a pilot study.

Authors:  Joerg Krebs; Paolo Pelosi; Charalambos Tsagogiorgas; Markus Alb; Thomas Luecke
Journal:  Crit Care       Date:  2009-10-05       Impact factor: 9.097

10.  Is the way to man's heart (and lung) through the abdomen?

Authors:  Robert L Owens; R Scott Harris; Atul Malhotra
Journal:  Crit Care       Date:  2009-11-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.